皮肤 T 细胞淋巴瘤

预约门诊

分期

如果您被确诊患有皮肤 T 细胞淋巴瘤（CTCL），下一步是查明癌症的扩散程度和位置。这称为分期。医务人员可能会利用影像学检查和活检，通过观察癌症病灶的大小、位置以及从原发部位扩散的距离来确定分期。医护团队会根据分期制定您的治疗计划。

不同类型的皮肤 T 细胞淋巴瘤的分期方式并不完全相同。CTCL 的分期通常为 1 至 4 期，用于描述癌症累及皮肤、淋巴结和器官的范围。对于蕈样肉芽肿和塞扎里综合征，分期还用于描述癌症对血液的累及情况。分期数值越高，代表癌症进展程度越严重。

  • 皮肤。 较低的分期数值通常意味着癌症仅局限于较小的皮肤区域。随着分期数值的增加，癌症可能会进展到更大范围的皮肤，或在皮肤上形成肿瘤。较高的分期还意味着癌症已经扩散到身体的其他部位。
  • 淋巴结。 随着分期数值的增加，意味着可能有更多的淋巴结受到累及。较高的分期还可能意味着受累淋巴结位于体内更深处的部位。
  • 器官。 较高的分期通常意味着癌症已扩散到皮肤和淋巴结以外的其他器官。
申请预约
诊断与治疗医生与科室
April 29, 2026

Living with 皮肤 T 细胞淋巴瘤?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

shenriq
Essential Thrombocythemia: Looking for information and support

675 Replies Mon, Jul 13, 2026

nbadry
What are your experiences with lenalidomide (Revlimid) for MDS?

32 Replies Sun, Jul 12, 2026

eddb
Anyone else find the side effects of Hydrea 500MG frightening?

209 Replies Thu, Jul 09, 2026

See more discussions
  1. DeVita VT Jr, et al., eds. Cutaneous lymphomas. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Wolters Kluwer; 2023. Accessed Jan. 30, 2026.
  2. Primary cutaneous lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelinesdetail?category=1&id=1491. Accessed Oct. 7, 2024.
  3. AskMayoExpert. Mycosis fungoides and Sezary syndrome (adult). Mayo Clinic; 2024.
  4. Cutaneous T-cell lymphoma in adult. VisualDx. https://www.visualdx.com. Accessed Nov. 7, 2024.
  5. Cutaneous T-cell lymphoma. American Academy of Dermatology. https://www.aad.org/public/diseases/a-z/ctcl-overview. Accessed Nov. 11, 2024.
  6. Cutaneous T-cell lymphoma. Leukemia & Lymphoma Society. https://www.lls.org/publications?field_booklets_language_target_id_1=351&field_booklets_category_target_id=344&sort_by=title&view-type=card. Accessed Nov. 11, 2024.
  7. Niederhuber JE, et al., eds. Cutaneous T-cell lymphoma and cutaneous B-cell lymphoma. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  8. Lavin L, et al. Cutaneous T cell lymphoma following dupilumab therapy in patients with atopic dermatitis: Clinical review and recommendations. American Journal of Clinical Dermatology. 2025; doi:10.1007/s40257-025-00955-7.
  9. Mycosis fungoides and other cutaneous T-cell lymphomas treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/hp/mycosis-fungoides-treatment-pdq. Accessed Jan. 30, 2026.
  10. Hoppe R, et al. Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  11. Freedman S, et al. Clinical manifestations, pathologic features, and diagnosis of subcutaneous panniculitis-like T cell lymphoma. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  12. Elsevier Point of Care. Clinical Overview: Cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome). https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  13. Willemze R. Primary cutaneous T cell lymphomas, rare subtypes. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  14. Cutaneous lymphomas. National Comprehensive Cancer Care Network.https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1549. Accessed Jan. 30, 2026.
  15. Salama M, et al., eds. Indolent and aggressive mature T-cell and natural killer-cell lymphomas. In: Atlas of Diagnostic Hematology. Elsevier; 2026. https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  16. American College of Surgeons. Primary cutaneous lymphomas. In: AJCC Cancer Staging System. American College of Surgeons; 2026. https://online.statref.com. Accessed Jan. 29, 2026.

相关

相关医疗程序

产品与服务

皮肤 T 细胞淋巴瘤